![Torsten Fahrig](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Torsten Fahrig
Financieel Directeur/CFO bij RESprotect GmbH
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Gouya Ram-liebig | M | 59 |
UroTiss GmbH
![]() UroTiss GmbH Medical/Nursing ServicesHealth Services UroTiss Gmbh researches, develops, and manufactures pharmaceuticals for the treatment of urethral strictures and hypospadias. The company was founded by Dr. Gouya Ram-Liebig in 2005 and is headquartered in Dortmund, Germany. | 16 jaar |
Rudolf Fahrig | M | 83 |
RESprotect GmbH
![]() RESprotect GmbH Pharmaceuticals: OtherHealth Technology RESprotect GmbH develops drugs for the treatment of chemotherapeutic disease. It holds interest in the prevention and treatment of chemotherapeutic drug resistance and radiation therapyresistance. The firms offers products for the indication of cancer. The company was founded by Rudolf Fahrig in 2000 and is headquartered in Dresden, Germany. | 24 jaar |
Sören Liebig | M | 57 |
UroTiss GmbH
![]() UroTiss GmbH Medical/Nursing ServicesHealth Services UroTiss Gmbh researches, develops, and manufactures pharmaceuticals for the treatment of urethral strictures and hypospadias. The company was founded by Dr. Gouya Ram-Liebig in 2005 and is headquartered in Dortmund, Germany. | 19 jaar |
Jörg-Christian Heinrich | M | - |
RESprotect GmbH
![]() RESprotect GmbH Pharmaceuticals: OtherHealth Technology RESprotect GmbH develops drugs for the treatment of chemotherapeutic disease. It holds interest in the prevention and treatment of chemotherapeutic drug resistance and radiation therapyresistance. The firms offers products for the indication of cancer. The company was founded by Rudolf Fahrig in 2000 and is headquartered in Dresden, Germany. | - |
Klaus Kutz | M | - |
RESprotect GmbH
![]() RESprotect GmbH Pharmaceuticals: OtherHealth Technology RESprotect GmbH develops drugs for the treatment of chemotherapeutic disease. It holds interest in the prevention and treatment of chemotherapeutic drug resistance and radiation therapyresistance. The firms offers products for the indication of cancer. The company was founded by Rudolf Fahrig in 2000 and is headquartered in Dresden, Germany. | - |
Andreas Koch | M | - |
RESprotect GmbH
![]() RESprotect GmbH Pharmaceuticals: OtherHealth Technology RESprotect GmbH develops drugs for the treatment of chemotherapeutic disease. It holds interest in the prevention and treatment of chemotherapeutic drug resistance and radiation therapyresistance. The firms offers products for the indication of cancer. The company was founded by Rudolf Fahrig in 2000 and is headquartered in Dresden, Germany. | - |
Jürgen Bednarz | M | - |
UroTiss GmbH
![]() UroTiss GmbH Medical/Nursing ServicesHealth Services UroTiss Gmbh researches, develops, and manufactures pharmaceuticals for the treatment of urethral strictures and hypospadias. The company was founded by Dr. Gouya Ram-Liebig in 2005 and is headquartered in Dortmund, Germany. | - |
Clemens Unger | M | - |
RESprotect GmbH
![]() RESprotect GmbH Pharmaceuticals: OtherHealth Technology RESprotect GmbH develops drugs for the treatment of chemotherapeutic disease. It holds interest in the prevention and treatment of chemotherapeutic drug resistance and radiation therapyresistance. The firms offers products for the indication of cancer. The company was founded by Rudolf Fahrig in 2000 and is headquartered in Dresden, Germany. | - |
Robert Schiestl | M | - |
RESprotect GmbH
![]() RESprotect GmbH Pharmaceuticals: OtherHealth Technology RESprotect GmbH develops drugs for the treatment of chemotherapeutic disease. It holds interest in the prevention and treatment of chemotherapeutic drug resistance and radiation therapyresistance. The firms offers products for the indication of cancer. The company was founded by Rudolf Fahrig in 2000 and is headquartered in Dresden, Germany. | - |
Siegfried Knasmüller | M | - |
RESprotect GmbH
![]() RESprotect GmbH Pharmaceuticals: OtherHealth Technology RESprotect GmbH develops drugs for the treatment of chemotherapeutic disease. It holds interest in the prevention and treatment of chemotherapeutic drug resistance and radiation therapyresistance. The firms offers products for the indication of cancer. The company was founded by Rudolf Fahrig in 2000 and is headquartered in Dresden, Germany. | - |
Bernhard Matter | M | - |
RESprotect GmbH
![]() RESprotect GmbH Pharmaceuticals: OtherHealth Technology RESprotect GmbH develops drugs for the treatment of chemotherapeutic disease. It holds interest in the prevention and treatment of chemotherapeutic drug resistance and radiation therapyresistance. The firms offers products for the indication of cancer. The company was founded by Rudolf Fahrig in 2000 and is headquartered in Dresden, Germany. | - |
Herbert Müsch | M | - |
RESprotect GmbH
![]() RESprotect GmbH Pharmaceuticals: OtherHealth Technology RESprotect GmbH develops drugs for the treatment of chemotherapeutic disease. It holds interest in the prevention and treatment of chemotherapeutic drug resistance and radiation therapyresistance. The firms offers products for the indication of cancer. The company was founded by Rudolf Fahrig in 2000 and is headquartered in Dresden, Germany. | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Duitsland | 12 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Torsten Fahrig
- Persoonlijk netwerk